DHW-208, A Novel Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Has Anti-Hepatocellular Carcinoma Activity Through Promoting Apoptosis and Inhibiting Angiogenesis

Hepatocellular carcinoma (HCC) is one of the most common tumors worldwide with high prevalence and lethality. Due to insidious onset and lack of early symptoms, most HCC patients are diagnosed at advanced stages without adequate methods but systemic therapies. PI3K/AKT/mTOR signaling pathway plays a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shu, Wu, Yuting, Liu, Mingyue, Zhao, Qingchun, Jian, Lingyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315107/
https://www.ncbi.nlm.nih.gov/pubmed/35903690
http://dx.doi.org/10.3389/fonc.2022.955729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315107/
https://www.ncbi.nlm.nih.gov/pubmed/35903690
http://dx.doi.org/10.3389/fonc.2022.955729

Ejemplares similares